Mortality risk stratification for Takotsubo syndrome: Evaluating CRP measurement alongside the InterTAK prognostic score.

Date publication

janvier 2025

Journal

ESC heart failure

Auteurs

Membres identifiés du Cancéropôle Est :
Pr SCHINI-KERTH Valérie

Tous les auteurs :
Faucher L, Matsushita K, Kikuchi S, Tatarcheh T, Marchandot B, Granier A, Amissi S, Trimaille A, Jesel L, Ohlmann P, Hibi K, Schini-Kerth V, Morel O

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/39821701

Résumé

Initially described as a benign acute cardiomyopathy, Takotsubo syndrome has been linked to elevated mortality rates. Emerging evidence suggests that unresolved myocardial inflammation may contribute to this adverse prognosis. This study aimed to evaluate the incremental prognostic utility of C-reactive protein (CRP) in conjunction with the InterTAK prognosis score for stratifying long-term mortality in Takotsubo syndrome.

Mots clés

Cardiomyopathy, Catecholamine, Endothelium, Inflammation, InterTAK, Takotsubo syndrome

Référence

ESC Heart Fail. 2025 01 16;: